Drug improves health in obese patients on a diet

03/16/2010 | Medscape (free registration)

Australian scientists report that obese patients who were placed on a low-calorie diet and took ezetimibe had reduced inflammation, hepatic steatosis and cardiovascular risk factors. A study of 25 obese patients found those who received ezetimibe showed lower levels of triglycerides, LDL cholesterol and other markers after four months compared with those who dieted only.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC